Detalhe da pesquisa
1.
Inhibition of glutamate carboxypeptidase II (GCPII) activity as a treatment for cognitive impairment in multiple sclerosis.
Proc Natl Acad Sci U S A
; 109(49): 20101-6, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169655
2.
Opioids and migration, chemotaxis, invasion, and adhesion of human cancer cells.
Neuropeptides
; 41(6): 441-52, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17910895
3.
Prevention and diminished expression of experimental autoimmune encephalomyelitis by low dose naltrexone (LDN) or opioid growth factor (OGF) for an extended period: Therapeutic implications for multiple sclerosis.
Brain Res
; 1381: 243-53, 2011 Mar 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21256121
4.
Opioid growth factor suppresses expression of experimental autoimmune encephalomyelitis.
Brain Res
; 1310: 154-61, 2010 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19931226
5.
Endogenous opioids regulate expression of experimental autoimmune encephalomyelitis: a new paradigm for the treatment of multiple sclerosis.
Exp Biol Med (Maywood)
; 234(11): 1383-92, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19855075
6.
A reduced carbohydrate, increased protein diet stabilizes glycemic control and minimizes adipose tissue glucose disposal in rats.
J Nutr
; 136(7): 1855-61, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16772449